Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Study of Professional and Individual Factors of Covi-19 and Impact on Return to Work

  • Read more about Study of Professional and Individual Factors of Covi-19 and Impact on Return to Work

Incidence of MIS-C and Other Complications Following SARS-CoV-2 Infection

  • Read more about Incidence of MIS-C and Other Complications Following SARS-CoV-2 Infection

COVID-19 and Disease Progression to the Severe Form: A Study on the Use of Monoclonal Antibodies Against SARS-CoV-2

  • Read more about COVID-19 and Disease Progression to the Severe Form: A Study on the Use of Monoclonal Antibodies Against SARS-CoV-2

Markers of Severity (CD177,S100A8 &S100A12) in Sever Acute Respiratory Syndrome Coronavirus 2(SARS-COV-2) Patients

  • Read more about Markers of Severity (CD177,S100A8 &S100A12) in Sever Acute Respiratory Syndrome Coronavirus 2(SARS-COV-2) Patients

SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies

  • Read more about SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies

Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag ULTRA Test (ASPIRE-2)

  • Read more about Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag ULTRA Test (ASPIRE-2)

A Study to Evaluate Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Variant (COVID-19) mRNA Vaccines

  • Read more about A Study to Evaluate Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Variant (COVID-19) mRNA Vaccines

Change in Antibody Levels Following SARS-CoV-2 (Covid-19) Vaccinations

  • Read more about Change in Antibody Levels Following SARS-CoV-2 (Covid-19) Vaccinations

Understanding the Long-term Impact of COVID-19 in Adults (RECOVER)

  • Read more about Understanding the Long-term Impact of COVID-19 in Adults (RECOVER)

Intervention to Prevent Household and Community Spread of COVID-19 Among Latinos

  • Read more about Intervention to Prevent Household and Community Spread of COVID-19 Among Latinos

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 136
  • Page 137
  • Page 138
  • Page 139
  • Current page 140
  • Page 141
  • Page 142
  • Page 143
  • Page 144
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA